Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02741661
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CZI | (2R)-8-BENZYL-2-HYDROPEROXY-6-(4- HYDROXYPHENYL)-2-(4-IODOBENZYL)- 7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 3(2H)-ONE | A,B | 1UHI | 0.86 |  |
CZB | (2S,8R)-8-BENZYL-2-(4-BROMOBENZYL)- 2-HYDROPEROXY-6-(4-HYDROXYPHENYL)- 7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 3(2H)-ONE | A,B | 1UHJ | 0.82 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A,B | 2PSJ | 0.7 | |
| CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 2F8P | 0.7 | |
| CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 1S36 | 0.7 | |
CH7 | [(4Z)-4-(4-HYDROXYBENZYLIDENE)- 5-OXO-2-(3,4,5,6-TETRAHYDROPYRIDIN- 2-YL)-4,5-DIHYDRO-1H-IMIDAZOL-1- YL]ACETIC ACID | A,B | 1XAE | 0.7 | |
| CH7 | [(4Z)-4-(4-HYDROXYBENZYLIDENE)- 5-OXO-2-(3,4,5,6-TETRAHYDROPYRIDIN- 2-YL)-4,5-DIHYDRO-1H-IMIDAZOL-1- YL]ACETIC ACID | A,B,C,D | 2OGR | 0.7 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1ZGO | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E | 3CGL | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1G7K | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1GGX | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 2ARL | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2C9I | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 2VAD | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 2H8Q | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1ZGP | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2IB5 | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 1MOV | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 1MOU | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2VAE | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2P4M | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2C9J | 0.71 | |
CRU | 4-[(4Z)-1-(CARBOXYMETHYL)-4-(4- HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO- 1H-IMIDAZOL-2-YL]-4-IMINOBUTANOIC ACID | A,B,C,D | 1YZW | 0.72 | |
MOY | [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL- 2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN- 5-YL](PHENYL)METHANONE | A,B | 2IEH | 0.72 | |
TI2 | (2-SULFANYL-3-PHENYLPROPANOYL)- PHE-TYR | A | 1QF0 | 0.7 | |
GAH | N-{[(2S)-1-(N-{[4-({[AMINO(IMINO)METHYL]AMINO}METHYL)CYCLOHEXYL]CARBONYL}- 3-CYCLOHEXYL-L-ALANYL)AZETIDIN- 2-YL]CARBONYL}-L-TYROSYL-N~6~-[AMINO(IMINO)METHYL]- L-LYSINAMIDE | A,H | 1XM1 | 0.71 | |
OI1 | 3-(4-HYDROXYBENZYL)-2-[1-({[2-(4- HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]- 4-OXO-3,6,11,11A-TETRAHYDRO-4H- PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM- 1-OLATE | A,B | 1Q9D | 0.76 | |
CTZ | C2-HYDROXY-COELENTERAZINE | A | 2HPS | 0.86 | |
| CTZ | C2-HYDROXY-COELENTERAZINE | A | 1EL4 | 0.86 | |
CZN | (2S,8R)-8-BENZYL-2-HYDROPEROXY- 6-(4-HYDROXYPHENYL)-2-(2-NAPHTHYLMETHYL)- 7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 3(2H)-ONE | A,B | 1UHK | 0.81 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.71 | |
CZP | (8R)-8-(CYCLOPENTYLMETHYL)-2-HYDROPEROXY- 2-(4-HYDROXYBENZYL)-6-(4-HYDROXYPHENYL)- 7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 3(2H)-ONE | A,B | 1UHH | 0.84 | |
LI7 | (3E)-3-[(4-HYDROXYPHENYL)IMINO]- 1H-INDOL-2(3H)-ONE | A | 1YXX | 0.71 | |
CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1QV1 | 0.85 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1JF2 | 0.85 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1SL9 | 0.85 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1JF0 | 0.85 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1QV0 | 0.85 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A,B | 1EJ3 | 0.85 | |
CFY | [(2S)-2-{(2R)-2-[(1S)-1-amino-2- phenylethyl]-2-hydroxy-2,5-dihydro- 1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)- 5-oxo-2,5-dihydro-1H-imidazol-1- yl]acetic acid | A,B,C,D | 2ZMW | 0.73 | |
| CFY | [(2S)-2-{(2R)-2-[(1S)-1-amino-2- phenylethyl]-2-hydroxy-2,5-dihydro- 1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)- 5-oxo-2,5-dihydro-1H-imidazol-1- yl]acetic acid | A | 2ZMU | 0.73 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.73 | |
099 | (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)- N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro- 1H-inden-1-yl]butanediamide | A,B | 3HYG | 0.71 | |